Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
08/11/2022* -- Results Q1 2023 -- 0.59 --
08/11/2022* 08:00 EST Earnings Call Q1 2023 -- -- --
05/10/2022 -- Results Q4 2022 0.65 0.60 8.25%
05/10/2022 08:00 EST Earnings Call Q4 2022 -- -- --
02/08/2022 -- Results Q3 2022 0.84 0.73 14.49%
02/08/2022 08:00 EST Earnings Call Q3 2022 -- -- --
11/09/2021 -- Results Q2 2022 0.60 0.61 -0.95%
11/09/2021 08:00 EST Earnings Call Q2 2022 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 08/11/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 05/10/2022
Beat/Miss Upgrade
Return Since 5.92%
Last FQE 03/31/2022
Next FQE 06/30/2022

Profile

Edit
Haemonetics Corp sells products used to process, handle, and analyze blood. The firm sells products in three categories: Plasma, Blood Center and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, and anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood. Hospital, which is comprised of Hemostasis Management, Cell Salvage, Transfusion Management and Vascular Closure products, includes devices and methodologies for measuring coagulation characteristics of blood, surgical blood salvage systems, specialized blood cell processing systems and disposables, blood transfusion management software and vascular closure devices.
URL https://www.haemonetics.com
Investor Relations URL https://haemonetics.gcs-web.com
HQ State/Province Massachusetts
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Small Cap/Blend
Next Earnings Release Aug. 11, 2022 (est.)
Last Earnings Release May. 10, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-13.84%
24.69%
44.48%
72.26%
14.84%
3.35%
-55.33%
8.60%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-15.45%
-8.79%
1.45%
17.86%
-13.31%
45.38%
3.76%
-17.02%
-9.21%
48.77%
-27.11%
-3.87%
108.7%
82.59%
69.02%
45.23%
-39.55%
30.25%
-9.96%
-17.98%
28.01%
-43.27%
91.30%
9.15%
20.74%
5.92%
-41.45%
103.4%
10.58%
32.13%
7.94%
-7.08%
15.74%
As of May 16, 2022.

Profile

Edit
Haemonetics Corp sells products used to process, handle, and analyze blood. The firm sells products in three categories: Plasma, Blood Center and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, and anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood. Hospital, which is comprised of Hemostasis Management, Cell Salvage, Transfusion Management and Vascular Closure products, includes devices and methodologies for measuring coagulation characteristics of blood, surgical blood salvage systems, specialized blood cell processing systems and disposables, blood transfusion management software and vascular closure devices.
URL https://www.haemonetics.com
Investor Relations URL https://haemonetics.gcs-web.com
HQ State/Province Massachusetts
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Small Cap/Blend
Next Earnings Release Aug. 11, 2022 (est.)
Last Earnings Release May. 10, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
NIFE 137451.0 USD 4.25%
HNVIX 16.12M USD 3.48%
JSCCX 17.05M USD 2.31%
CVAR 401385.0 USD 1.78%
HRSGX 16.43M USD 1.68%
XHE 6.572M USD 1.60%
NBGAX 131.81M USD 1.17%
QCSCX 15.47M USD 1.15%
RPMRX 16.00M USD 0.84%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter HAE Tweets